Your browser doesn't support javascript.
loading
An LKB1-mitochondria axis controls TH17 effector function.
Baixauli, Francesc; Piletic, Klara; Puleston, Daniel J; Villa, Matteo; Field, Cameron S; Flachsmann, Lea J; Quintana, Andrea; Rana, Nisha; Edwards-Hicks, Joy; Matsushita, Mai; Stanczak, Michal A; Grzes, Katarzyna M; Kabat, Agnieszka M; Fabri, Mario; Caputa, George; Kelly, Beth; Corrado, Mauro; Musa, Yaarub; Duda, Katarzyna J; Mittler, Gerhard; O'Sullivan, David; Sesaki, Hiromi; Jenuwein, Thomas; Buescher, Joerg M; Pearce, Edward J; Sanin, David E; Pearce, Erika L.
Affiliation
  • Baixauli F; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Piletic K; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Puleston DJ; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Villa M; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Field CS; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Flachsmann LJ; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Quintana A; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Rana N; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Edwards-Hicks J; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Matsushita M; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Stanczak MA; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Grzes KM; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Kabat AM; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Fabri M; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Caputa G; University of Cologne, Department of Dermatology, Cologne, Germany.
  • Kelly B; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Corrado M; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Musa Y; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Duda KJ; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Mittler G; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • O'Sullivan D; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Sesaki H; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Jenuwein T; Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Buescher JM; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Pearce EJ; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Sanin DE; Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany.
  • Pearce EL; Department of Oncology, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA.
Nature ; 610(7932): 555-561, 2022 10.
Article in En | MEDLINE | ID: mdl-36171294
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: AMP-Activated Protein Kinases / Th17 Cells / Mitochondria Type of study: Prognostic_studies Language: En Journal: Nature Year: 2022 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: AMP-Activated Protein Kinases / Th17 Cells / Mitochondria Type of study: Prognostic_studies Language: En Journal: Nature Year: 2022 Type: Article Affiliation country: Germany